Celldex Therapeutics, Inc. (CLDX): Price and Financial Metrics
Celldex Therapeutics, Inc. (CLDX)
Today's Latest Price: $15.38 USD
0.01 (0.07%)
Updated Oct 29 4:00pm
Add CLDX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CLDX Stock Summary
- The ratio of debt to operating expenses for Celldex Therapeutics Inc is higher than it is for about just 7.79% of US stocks.
- CLDX's price/sales ratio is 136.77; that's higher than the P/S ratio of 97.8% of US stocks.
- In terms of volatility of its share price, CLDX is more volatile than 97.54% of stocks we're observing.
- Stocks that are quantitatively similar to CLDX, based on their financial statements, market capitalization, and price volatility, are MESO, KLIC, CBIO, ETTX, and LOGC.
- Visit CLDX's SEC page to see the company's official filings. To visit the company's web site, go to www.celldex.com.
CLDX Stock Price Chart Interactive Chart >
CLDX Price/Volume Stats
| Current price | $15.38 | 52-week high | $19.32 |
| Prev. close | $15.37 | 52-week low | $1.50 |
| Day low | $15.00 | Volume | 233,800 |
| Day high | $15.60 | Avg. volume | 1,200,257 |
| 50-day MA | $13.89 | Dividend yield | N/A |
| 200-day MA | $7.43 | Market Cap | 601.76M |
Celldex Therapeutics, Inc. (CLDX) Company Bio
Celldex Therapeutics is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. The company was founded in 2004 and is based in Hampton, New Jersey.
Loading social stream, please wait...